Abrdn Healthcare Investors Fund HQH

$18.32 +0.01 (0.05%)

Valuation

Market cap
940,106,000
Revenue TTM
$58,118,274
Net income TTM
$56,334,828
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
952
Avg volume
125,346
Day's range
$18.32 – $18.32
Shares out
50,625,000
Stochastic %K
13%
Beta
0.76
Analysts
Strong Buy
Price target
—

Price

Company profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with...

Show more

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Industry
Asset Management
Sector
Financial Services
Phone
215 405 5700
Address
1900 Market Street, Suite 200, Philadelphia, United States

Latest news

No headlines yet.